v1
A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers.
Identifier:nobleid.org/w1/20260515/82EB91AC
Type:Conference Paper
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/82EB91AC)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims